Last $92.59 USD
Change Today -0.53 / -0.57%
Volume 883.5K
MJN On Other Exchanges
Symbol
Exchange
Berlin
New York
As of 6:40 PM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

mead johnson nutrition co (MJN) Snapshot

Open
$93.07
Previous Close
$93.12
Day High
$93.14
Day Low
$92.08
52 Week High
07/2/14 - $94.00
52 Week Low
07/24/13 - $70.54
Market Cap
18.7B
Average Volume 10 Days
1.1M
EPS TTM
$3.50
Shares Outstanding
202.1M
EX-Date
06/19/14
P/E TM
26.5x
Dividend
$1.50
Dividend Yield
1.54%
Current Stock Chart for MEAD JOHNSON NUTRITION CO (MJN)

mead johnson nutrition co (MJN) Details

Mead Johnson Nutrition Company manufactures, distributes, and sells infant formulas, children’s nutrition, and other nutritional products. Its infant formula products include formulas for routine feeding; solutions formulas for addressing mild feeding problems, such as gas/fussiness, soy formula, lactose intolerance, anti-regurgitation, and cow’s milk protein allergy risk; and specialty formula products, including formulas for addressing severe intolerance, formulas for premature and low birth weight infants, and medical nutrition products. Its children’s nutrition products comprise products for meeting children’s nutritional needs at one to three years of age, three to five years of age, and beyond five years of age. The company’s children’s nutrition products also include nutritionally-balanced milk supplements for children targeting nutritional needs during specific stages of development; powered milk supplements; and milk modifiers in powder form. It also produces a range of other products, including pre-natal and post-natal nutritional supplements for expectant and nursing mothers. The company markets its products primarily under the Enfamil Premium, Enfamil Premium Newborn, Enfamil A+, Enfalac A+, Enfapro A+, Enfamil Gentlease, Enfapro Premium, SanCor Bebé, SanCor Bebé Premium, Enfamil ProSobee, Enfamil LactoFree, Enfamil AR, Enfamil HA, Enfamil Comfort, Enfamil for Supplementing, Nutramigen, Nutramigen AA, Pregestimil, Enfamil Premature, Enfacare, Enfagrow, Enfagrow A+, Enfagrow Premium, Enfamil Human Milk Fortifier, Sustagen KID, Lactum, Alacta, ChocoMilk, and Cal-C-Tose brand names. It sells its products to mothers, health care professionals, and retailers in approximately 50 countries in North America, Europe, Asia, and Latin America. The company was founded in 1905 and is headquartered in Glenview, Illinois.

7,200 Employees
Last Reported Date: 02/18/14
Founded in 1905

mead johnson nutrition co (MJN) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $893.8K
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $603.8K
Chief Development Officer and Senior Vice Pre...
Total Annual Compensation: $548.0K
Senior Vice President, General Counsel and Se...
Total Annual Compensation: $454.6K
Senior Vice President of Global Supply Chain
Total Annual Compensation: $377.3K
Compensation as of Fiscal Year 2013.

mead johnson nutrition co (MJN) Key Developments

Mead Johnson Nutrition Company and Mead Johnson & Company, LLC Enter into Five Year Revolving Credit Facility Agreement

On June 27, 2014, Mead Johnson Nutrition Company (company), Mead Johnson & Company, LLC (MJ&C), a wholly owned subsidiary of the company, and various other subsidiaries of the company party thereto from time to time, entered into amendment no. 1 to the five year revolving credit facility agreement dated as of June 17, 2011 among the Company, MJ&C, various subsidiaries of the company parties thereto from time to time, various financial institutions and JPMorgan Chase Bank, N.A., as administrative agent. The first amendment provided for, among other things, an increase in the aggregate amount available for borrowing from $500 million to $750 million (which amount may be increased from time to time up to $1 billion at the request of the company, subject to obtaining additional commitments and other customary conditions), the addition of certain financial institutions as lenders and the extension of the maturity date from June 2016 to June 2019.

Mead Johnson Nutrition Company Provides Earnings Guidance for the Full Year of 2014

Mead Johnson Nutrition Company provided earnings guidance for the full year of 2014. Non-GAAP earnings are expected to be in the range of $3.60 to $3.72 per share. Operating expenses should be between 38% and 38.5%.

Mead Johnson Considers Acquisitions

Mead Johnson Nutrition Company (NYSE:MJN) will Consider acquisitions. Pete Leemputte, Executive Vice President and Chief Financial Officer of Mead Johnson said, "But the highest priority use of our free cash flow, looking forward, is to pursue growth through acquisitions within our core business.”

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MJN:US $92.59 USD -0.53

MJN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Inner Mongolia Yili Industrial Group Co Ltd CNY32.30 CNY +0.05
Perrigo Co PLC $146.15 USD -1.12
Kalbe Farma Tbk PT 1,735 -10.00
Synutra International Inc $6.81 USD +0.04
Hain Celestial Group Inc/The $88.99 USD -0.17
View Industry Companies
 

Industry Analysis

MJN

Industry Average

Valuation MJN Industry Range
Price/Earnings 28.5x
Price/Sales 4.4x
Price/Book 54.4x
Price/Cash Flow 28.3x
TEV/Sales 3.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEAD JOHNSON NUTRITION CO, please visit www.mjn.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.